References
- Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 1983;62(1):14–31
- Gordon SG, Cross BA. A factor X-activating cysteine protease from malignant tissue. J Clin Invest 1981;67(6): 1665–71
References
- Trousseau A. Lectures on clinical medicine delivered at the Hotel Dieu, Paris. 3d ed, vol 4. Cormack JR, transl. London: New Sydenham Society, 1872: 280–332
- Edwards RL, Rickles FR, Moritz TE, et al. Abnormalities of blood coagulation tests in patients with cancer. Am J Clin Pathol 1987: 88(5): 596–602
- Rickles FR, Edwards RL, Barb C, et al. Abnormalities of blood coagulation in patients with cancer: fibrinopeptide A generation and tumor growth. Cancer 1983: 51(2): 301–7
- Edwards RL, Klaus M, Matthews E, et al. Heparin abolishes the chemotherapy-induced increase in plasma fibrinopeptide A levels. Am J Med 1990: 89(1): 25–8
- White RH, McGahan JP, Daschbach MM, et al. Diagnosis of deep-vein thrombosis using duplex ultrasound. Ann Intern Med 1989: 111(4): 297–304
- The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA 1990: 263(20): 2753–9
- Lokich JJ, Becker B. Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy. Cancer 1983: 52(9): 1586–9
- Bern MM, Bothe A Jr, Bistrian B, et al. Prophylaxis against central vein thrombosis with low-dose warfarin. Surgery 1986: 99(2): 216–21
- Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters: a randomized prospective trial. Ann Intern Med 1990: 112(6): 423–8
- Mitchell MC, Boitnott JK, Kaufman S, et al. Budd-Chiari syndrome: etiology, diagnosis and management. Medicine (Baltimore) 1982: 61 (4): 199–218
- Min KW, Gyorkey F, Sato C. Mucin-producing adenocarcinomas and nonbacterial thrombotic endocarditis: pathogenetic role of tumor mucin. Cancer 1980: 45(9): 2374–82
- Kurzrock R, Cohen PR. Erythromelalgia and myeloproliferative disorders. Arch Intern Med 1989: 149(1): 105–9
- Doll DC, Ringenberg QS, Yarbro JW. Vascular toxicity associated with antineoplastic agents. J Clin Oncol 1986: 4(9): 1405–17
- Levine MN, Gent M, Hirsh J, et al. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N Engl J Med 1988: 318(7): 404–7
- Monreal M, Lafoz E, Casals A, et al. Occult cancer in patients with deep venous thrombosis: a systematic approach. Cancer 1991: 67(2): 541–5
- Gore JM, Appelbaum JS, Greene HL, et al. Occult cancer in patients with acute pulmonary embolism. Ann Intern Med 1982: 96(5): 5 56–60
- Griffin MR, Stanson AW, Brown ML, et al. Deep venous thrombosis and pulmonary embolism: risk of subsequent malignant neoplasms. Arch Intern Med 1987: 147(11): 1907–11
- Prandoni P, Lensing AW, Buller HR, et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992: 327(16): 1128–33
- Olin JW, Young JR, Graor RA, et al. Treatment of deep vein thrombosis and pulmonary emboli in patients with primary and metastatic brain tumors: anticoagulants or inferior vena cava filter? Arch Intern Med 1987: 147(12): 2177–9
- Sack GH Jr, Levin J, Bell WR. Trousseaus syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore) 1977: 56(1): 1–37
- Bell WR, Starksen NF, Tong S, et al. Trousseaus syndrome: devastating coagulopathy in the absence of heparin. Am J Med 1985: 79(4): 423–30
- Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. Physician practices in the prevention of venous thromboembolism. Ann Intern Med 1991: 115(8): 591–5